News

December 26, 2012 — St. Jude Medical Inc. announced the first patient enrollment in its ILUMIEN I clinical study. The observational study is designed to show the optimal way optical coherence...

Corindus CorPath robotic system

Hospitals constantly try to predict what the future holds when planning new facilities and equipment purchases that need to last for the next decade. Martin Leon, M.D., attempted to answer that...

The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report investigations that will be presented at next month's ...

September 11, 2012 — Data presented at the 2012 ESC Congress in Munich from the prospective DeFACTO study show that, when compared to standard...

September 7, 2012 — St. Jude Medical Inc. announced results of the FAME II trial demonstrating that patients with...

Trends and new technology for cardiac computed tomography angiography (CCTA) were highlighted during the 2012 Society of Cardiovascular CT (SCCT) annual scientific meeting in July in Baltimore, Md...

May 24, 2012 — Volcano Corp. provided an overview of data from multiple ground-breaking clinical trials presented last week at the EuroPCR conference, a key international cardiology meeting held...

May 21, 2012 -- St. Jude Medical Inc. announced that data from the FAME II trial demonstrated a significant difference in the need for urgent revascularization when Fractional Flow Reserve (FFR)-...

April 23, 2012 - Abbott and St. Jude Medical announced ChoiceAlliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of interventional cardiology,...

March 29, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR)...

Coronary angiography is unable to accurately predict the severity of vessel narrowing, suggesting fractional flow reserve (FFR) functional tests should be added to help determine if a patient...

January 19, 2011 –– Interim analysis of the FAME II trial found a highly statistically significant reduction in the need for hospital readmission and urgent revascularization when fractional flow...

Each year I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking for the next big trend or technological innovations in cardiovascular devices. Below...

November 15, 2011 — The ADVISE clinical trial concluded that a new measure of stenosis severity — instantaneous wave-free ratio (iFR) — yielded similar results to traditional fractional flow...

November 9, 2011 — Volcano Corp. announced results from the ADVISE (ADenosine Vasodilator Independent Stenosis E...

November 1, 2011 – Volcano Corp., a developer and manufacturer of intravascular diagnosis and therapy guidance tools, said revenues for the third quarter of 2011 increased 18 percent versus the...

October 26, 2011 – St. Jude Medical announced it has received U.S. Food and Drug Administration (FDA) clearance for its Ilumien system, the first integrated diagnostic technology that combines...

May 23, 2011 – An analysis of the benefits to using a fractional flow reserve (FFR)-guided intervention strategy found that the technology can improve patient outcomes while saving significant...
May 18, 2011 – The world’s first system to integrate the functional and anatomical modalities of fractional flow reserve (FFR) and optical coherence tomography (OCT) into one platform will be...